Calling for benefit-risk evaluations of COVID-19 control measures.

Kampf, Günter; Kulldorff, Martin

Kampf, Günter; Kulldorff, Martin.

Kampf G; Institute for Hygiene and Environmental Medicine, University Medicine Greifswald, Greifswald 17475, Germany. Electronic address: guenter.kampf@uni-greifswald.de.
Kulldorff M; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Harvard Medical School, Boston, MA, USA.

Lancet ; 397(10274): 576-577, 2021 02 13.

Article in English | MEDLINE | ID: covidwho-1142325

Subject(s)

COVID-19/prevention & control; Risk Assessment; COVID-19/psychology; Depression/epidemiology; Emergency Service, Hospital/statistics & numerical data; Facilities and Services Utilization; Health Policy; Humans; Pandemics/prevention & control; Physical Distancing; Prevalence; SARS-CoV-2; Social Support

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Risk Assessment / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Qualitative research Limits: Humans Language: English Journal: Lancet Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google